Market Place
Sourcing Support
Mural Oncology to Participate in Two Upcoming Investor Conferences
11 Nov 2024 //
GLOBENEWSWIRE
Mural Oncology Presents Data at SITC 2024 Annual Meeting
07 Nov 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Inducement Grants Under Nasdaq LR5635(c)(4)
04 Nov 2024 //
GLOBENEWSWIRE
Mural Oncology To Present Data At 39th SITC 2024 Annual Meeting
07 Oct 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
03 Oct 2024 //
GLOBENEWSWIRE
Mural Oncology Inducement Grants Under Nasdaq Rule 5635(c)(4)
02 Oct 2024 //
GLOBENEWSWIRE
Mural Oncology`s Virtual Investor Day To Highlight Progress
26 Sep 2024 //
GLOBENEWSWIRE
Mural Oncology Appoints Sachiyo Minegishi To Board
23 Sep 2024 //
GLOBENEWSWIRE
Mural Oncology Hosts First Virtual Investor Day On Sept 26, 2024
10 Sep 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Inducement Grants Under Nasdaq
04 Sep 2024 //
GLOBENEWSWIRE
Mural Oncology to Present at Two Upcoming Investor Conferences
27 Aug 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Q2 2024 Results And Pipeline Progress
13 Aug 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Aug 2024 //
GLOBENEWSWIRE
Mural Oncology Appoints George Golumbeski To Board Of Directors
31 Jul 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Jul 2024 //
GLOBENEWSWIRE
Mural: Presenting & Investor Meetings At East Coast IDEAS Conference
05 Jun 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Jun 2024 //
GLOBENEWSWIRE
Mural Artistry-3 Clinical Data: Showcased At 2024 Asco Meeting
23 May 2024 //
GLOBENEWSWIRE
Mural Oncology Announces Q1 2024 Results, Business Update
14 May 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 May 2024 //
GLOBENEWSWIRE
Mural Oncology to Present at ASCO 2024 Annual Meeting
24 Apr 2024 //
GLOBENEWSWIRE
Mural Oncology Presents IL-18 & IL-12 Data at AACR
09 Apr 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Apr 2024 //
GLOBENEWSWIRE
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results
26 Mar 2024 //
GLOBENEWSWIRE
Mural Oncology Announces Upcoming Presentations at 2024 AACR
05 Mar 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Mar 2024 //
GLOBENEWSWIRE
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
27 Feb 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Feb 2024 //
GLOBENEWSWIRE
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
08 Jan 2024 //
GLOBENEWSWIRE
